Bicara Therapeutics schedules financial results announcement and business update for November 9

Bicara Therapeutics schedules financial results announcement and business update for November 9
Bicara Q3 2026 results set

Bicara Therapeutics will announce its third quarter 2026 financial results and provide a business update on Monday, November 9.

The company will also host a conference call for investors at 8:30 AM ET, with details and webcast registration available through its official channels.

Bicara Therapeutics recently initiated the FORTIFI-FLEX trial targeting HPV-negative head and neck cancer with a specific dosing regimen. The study marks a new step in the company’s clinical pipeline. Investors are expected to monitor updates on this and other programs during the upcoming results call.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.